Skip to main content

Immuneering Corp insider trading

IMRXNASDAQ
$4.07+0.04 (+0.99%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-37.7%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flow

Key players

  • BJBenjamin J. ZeskindPRESIDENT AND CEO4.9618%of company
  • PFPeter FeinbergDirector1.7946%of company
  • BMBrett Matthew HallCHIEF SCIENTIFIC OFFICER0.5913%of company
  • AGAndrew GengosChief Financial Officer0.3478%of company
  • TJThomas J. SchallDirector0.1152%of company
  • LRLeah R. NeufeldCHIEF PEOPLE OFFICER0.0457%of company
  • MMMallory MoralesSVP Finance, CAO0.0426%of company
  • HEHarold Eugene BrakewoodChief Business Officer0.0171%of company
  • DHDiana HausmanDirector0.0085%of company
  • MBMichael BookmanCHIEF LEGAL OFFICER, SECRETARY0.0075%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
IMRXBenjamin J. ZeskindPRESIDENT AND CEOOpen market purchase$10.9K+0.1%$4.56$10.9KJun 23, 2026Jun 24, 2026
IMRXBrett Matthew HallCHIEF SCIENTIFIC OFFICEROpen market purchase$25K+1.6%$4.15$25KJun 15, 2026Jun 16, 2026
IMRXHarold Eugene BrakewoodChief Business OfficerOpen market purchase$25K+90.5%$4.76$25KJan 16, 2026Jan 21, 2026
IMRXThomas J. SchallDirectorOpen market purchase$101K+40.9%$4.67$101KJan 15, 2026Jan 20, 2026
IMRXBrett Matthew HallCHIEF SCIENTIFIC OFFICEROpen market purchase$10.5K+0.6%$4.57$10.5KJan 15, 2026Jan 16, 2026
IMRXLeah R. NeufeldCHIEF PEOPLE OFFICEROpen market purchase$10.9K+11.3%$4.15$10.9KJan 13, 2026Jan 15, 2026
IMRXPeter FeinbergDirectorOpen market purchase$87K+1.8%$4.35$87KJan 12, 2026Jan 14, 2026
End of history · 7 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.